ZS Pharma, Inc.
CIK 0001459266
Revenue (TTM)
—
Q3 Nov 2015
Net Income (TTM)
−$106.76M
−20.5% YoY
Q3 Nov 2015
EPS Diluted (TTM)
—
Q3 Nov 2015
Gross Margin
—
Q3 Nov 2015
Operating Margin
—
Q3 Nov 2015
Net Margin
—
Q3 Nov 2015
Free Cash Flow (TTM)
—
Q3 Nov 2015
Cash
$64.35M
Q3 Nov 2015
Total Debt
$10.17M
Q3 Nov 2015
Shares Outstanding
25.27M sh
Q3 Nov 2015
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.